US 12329739
Isoflavonoid compounds and methods for the treatment of cancer
granted A61KA61K31/337A61K31/353
Quick answer
US patent 12329739 (Isoflavonoid compounds and methods for the treatment of cancer) held by Aardvark Therapeutics, Inc. expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aardvark Therapeutics, Inc.
- Grant date
- Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/337, A61K31/353, A61K31/555, A61K33/243